Bernard Lerer is Professor of Psychiatry and Head of Hadassah BrainLabs (https://brainlabs.org.il/) at Hadassah – Hebrew University Medical Center in Jerusalem. He was trained at the University of Cape Town Medical School, Hadassah Medical Center and Herzog Hospital, Jerusalem and was a post-doctoral research fellow with Prof. Samuel Gershon at Lafayette Clinic, Wayne State University, Detroit. His main research interest is the neurochemical mechanisms of antidepressants, mood stabilizers and brain stimulation as a basis for novel drug development. Recently, he has established a comprehensive preclinical and translational program focused on the psychiatric applications of psychedelic drugs. He has 386 PubMed listed original scientific publications and has edited 4 books. He has received numerous awards, most recently the 2019 Lifetime Achievement Award of the International Society for Affective Disorders (ISAD). He was Founding Editor-in-Chief of the International Journal of Neuropsychopharmacology (1998-2008). Bernard Lerer holds several patents in psychopharmacology and pharmacogenetics and has mentored more than 100 PhD and MSc students and psychiatrist research trainees.